Imugene Ltd has released a press release.
Imugene PD1-Vaxx Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Imugene
- Imugene Receives Positive Feedback From FDA
- VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1
- S&P DJI Announces September 2023 Quarterly Rebalance
- Preliminary Final Report
- Imugene completes $35M Placement & Launches c.$30M SPP
Later from Imugene
- Imugene Closes SPP Raising $18.2 million
- Azer-cel FDA IND Transferred to Imugene
- Imugene B Cell & OV Platforms Featured at ESMO Congress
- Imugene Phase 1 onCARlytics CD19 virus clinical trial opens
- Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene